ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Researchers create first stem cells using CRISPR genome activation – Science Daily

Continue reading

2018-01-19 Michael Zand NEWS

Rockefeller, Broad Settle CRISPR IP Dispute; EPO Denies Broad European Patent – GenomeWeb


Science Daily

Researchers create first stem cells using CRISPR genome activation
Science Daily
These proteins, called transcription factors, work by changing which genes are expressed in the cell, turning off genes associated with skin cells and turning on genes associated with stem cells. Building on this work, Ding and others previously …
How ‘stem cell‘ clinics became a Wild West for dodgy treatmentsNew Scientist
Stem cells could help penis, breast and bottom enlargement | Daily …Daily Mail
Men could soon make their penises bigger with liposuction and stem cell surgeryMetro
Genetic Engineering & Biotechnology News –EurekAlert (press release)
all 61 news articles »
Continue reading

2018-01-19 Michael Zand NEWS

Results from a meta-analysis in CLL: model supports MRD as primary endpoint in CLL chemo-immunotherapy trials – Lymphoma Hub

Lymphoma HubResults from a meta-analysis in CLL: model supports MRD as primary endpoint in CLL chemo-immunotherapy trialsLymphoma HubThis analysis was done to determine whether the treatment effect on MRD response in PB at the end of induction treatmen… Continue reading

2018-01-19 Michael Zand NEWS

CRISPR Activation of Single Genes Turns Skin Cells to Stem Cells – Genetic Engineering & Biotechnology News

CRISPR Activation of Single Genes Turns Skin Cells to Stem CellsGenetic Engineering & Biotechnology NewsA new way of inducing pluripotency has been demonstrated by scientists based at the Gladstone Institutes. Rather than fuss with the usual transcript… Continue reading

2018-01-19 Michael Zand NEWS

First Patient Dosed in Phase 1 Trial of P-BCMA-101 CAR T-Cell Therapy for Multiple Myeloma – Myeloma Research News


FierceBiotech

Rockefeller, Broad Settle CRISPR IP Dispute; EPO Denies Broad European Patent
GenomeWeb
This article has been updated from a previous version to include a statement from ERS Genomics on the EPO’s decision regarding the Broad Institute’s European patents. NEW YORK (GenomeWeb) – Rockefeller University and the Broad Institute said this week …
Arbitrator tells Rockefeller to stop blocking Broad Institute of MIT and Harvard CRISPR-Cas9 system patentScience Codex

all 3 news articles »

Continue reading

2018-01-19 Michael Zand NEWS

Broad Institute knocked back by European CRISPR patent ruling – FierceBiotech

FierceBiotechBroad Institute knocked back by European CRISPR patent rulingFierceBiotechDetermining who owns the intellectual property surrounding the gene-editing CRISPR/Cas9 technology has been a combative affair, and the Broad Institute just came out… Continue reading

2018-01-19 Michael Zand NEWS

Digital Map of T-cell Receptors Could Help Predict Cancer Patient Responses to Immunotherapy – Immuno-Oncology News

Immuno-Oncology NewsDigital Map of T-cell Receptors Could Help Predict Cancer Patient Responses to ImmunotherapyImmuno-Oncology NewsScientists at Johns Hopkins have created a digital map that addresses the variability of T-cell receptors, the chemical … Continue reading

2018-01-19 Michael Zand NEWS

Using electric fields to manipulate droplets on a surface could enable high-volume, low-cost biology experiments – Phys.Org


Myeloma Research News

First Patient Dosed in Phase 1 Trial of P-BCMA-101 CAR T-Cell Therapy for Multiple Myeloma
Myeloma Research News
The first patient has been dosed in a Phase 1 trial of P-BCMA-101, a new, more powerful type of CAR T-cell therapy to fight multiple myeloma, the therapy’s developer, Poseida Therapeutics, announced. The trial (NCT03288493), which will test the safety …

Continue reading

2018-01-19 Michael Zand NEWS
  • 1
  • …
  • 642
  • 643
  • 644
  • 645
  • 646
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Phys.Org

Using electric fields to manipulate droplets on a surface could enable high-volume, low-cost biology experiments
Phys.Org
I noticed this problem three years ago, when I was at a synthetic biology company where I built some of these microfluidic systems and mechanical machines that interact with them. I had to babysit these machines to make sure they didn’t explode …

and more »